SINGLE-CELL RESPONSE ANALYSIS
Preclinical
How is QuRIE-seq applied (approach and technology)?
QuRIE-seq
It compares the transcriptome between model organisms and patient samples to identify the best preclinical model for drug development.
Our single-cell response technology impact
on the pre-clinical phase:
Preclinical Model Selection
Identifies the model with the highest translational potential by comparing transcriptomic profiles.
Off-Target Effects
Detects unintended genetic and protein activity, enabling safer drug design.